S
Southern California Institute for Respiratory Diseases, Inc. | Los Angeles, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BLU-5937
JZP-258
Budesonide
Indacaterol
GB001
Symbicort®
(R)-2-amino-3-phenylpropylcarbamate Hydrochloride
Tiotropium
SUVN-G3031
S-600918
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 16 total trials
This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).
Enrolling
Refractory Chronic Cough
Drug: Placebo
Drug: BLU-5937
Trial sponsors
B
A
G
K
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems